Danish Pharmacovigilance Update, April 2017

22 May 2017

In this issue

  • Ciprofloxacin and risk of polyneuropathy and tendon disease/disorder
  • Rosuvastatin and risk of renal effects and rhabdomyolysis
  • The DKMA’s annual pharmacovigilance report 2016
  • Report on the use of and ADR reports on selected biological medicinal products now available
  • EU's list of recommendations on safety signals
  • Most recent Direct Healthcare Professional Communications (DHPCs)

Link

Danish Pharmacovigilance Update, April 2017